Gujarat Themis Biosyn Ltd
BSE:506879
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gujarat Themis Biosyn Ltd
BSE:506879
|
IN |
|
Sensei Biotherapeutics Inc
NASDAQ:SNSE
|
US |
|
Bridge Investment Group Holdings Inc
NYSE:BRDG
|
US |
|
Foxtron Vehicle Technologies Co Ltd
TWSE:2258
|
TW |
|
Franklin BSP Realty Trust Inc
NYSE:FBRT
|
US |
|
Intelligent Living Application Group Inc
NASDAQ:ILAG
|
HK |
|
S
|
Shenzhen Dobot Corp Ltd
HKEX:2432
|
CN |
|
V
|
Vienna Insurance Group Wiener Versicherung Gruppe AG
VSE:VIG
|
AT |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GUJTHEM's stock price target?
Not Available
GUJTHEM doesn't have any price targets made by Wall Street professionals.
What is Gujarat Themis Biosyn Ltd's Revenue forecast?
Projected CAGR
-17%
For the last 13 years the
compound annual growth rate for
Gujarat Themis Biosyn Ltd's revenue is
25%.
The projected
CAGR
for the next 8 years is
-17%.
What is Gujarat Themis Biosyn Ltd's Net Income forecast?
Projected CAGR
-26%
For the last 13 years the
compound annual growth rate for
Gujarat Themis Biosyn Ltd's net income is
30%.
The projected
CAGR
for the next 8 years is
-26%.